Welcome to LookChem.com Sign In|Join Free
  • or
4-Butylpiperidine is an organic compound that serves as a key reactant in the synthesis of various chemical compounds, particularly in the creation of 77-LH-28-1. It is known for its ability to penetrate the central nervous system (CNS) and act as a selective M1 muscarinic receptor agonist, making it a valuable component in the development of pharmaceuticals targeting the nervous system.

24152-39-4

Post Buying Request

24152-39-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

24152-39-4 Usage

Uses

Used in Pharmaceutical Industry:
4-Butylpiperidine is used as a reactant for the synthesis of 77-LH-28-1, a compound with potential applications in the treatment of various medical conditions. Its role in the synthesis process is crucial for the development of new drugs and therapies.
As a CNS Penetrant:
4-Butylpiperidine is used as a central nervous system penetrant, allowing it to cross the blood-brain barrier and interact with the brain's neural pathways. This property makes it a valuable component in the development of drugs targeting neurological disorders and conditions.
As a Selective M1 Muscarinic Receptor Agonist:
4-Butylpiperidine is used as a selective agonist for the M1 muscarinic receptor, a subtype of the muscarinic acetylcholine receptors. Its selective action on the M1 receptor makes it a potential candidate for the development of drugs targeting cognitive functions, as well as other conditions related to the muscarinic system.

Check Digit Verification of cas no

The CAS Registry Mumber 24152-39-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,4,1,5 and 2 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 24152-39:
(7*2)+(6*4)+(5*1)+(4*5)+(3*2)+(2*3)+(1*9)=84
84 % 10 = 4
So 24152-39-4 is a valid CAS Registry Number.
InChI:InChI=1/C9H19N.ClH/c1-2-3-4-9-5-7-10-8-6-9;/h9-10H,2-8H2,1H3;1H

24152-39-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-butylpiperidine

1.2 Other means of identification

Product number -
Other names 4-n-Butylpiperidine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:24152-39-4 SDS

24152-39-4Relevant academic research and scientific papers

Efficient Solution-Phase Parallel Synthesis of 4-Substituted N-Protected Piperidines

Wang, Xiaoyang,Kauppi, Anna M.,Olsson, Roger,Almqvist, Fredrik

, p. 4586 - 4592 (2007/10/03)

Practical conditions for the synthesis of 4-substituted N-protected piperidines through CuCN·2LiBr-catalyzed organozinc additions to 1-acylpyridinium salts and subsequent hydrogen-transfer hydrogenation have been established. The reaction sequence is performed at room temperature and provides 4-substituted N-protected piperidines in excellent overall yields without the isolation of intermediate dihydropyridines, In those cases in which the organozinc addition results in mixtures of 2- and 4-substituted dihydropyridines, the 2-substituted isomers are efficiently scavenged with maleic anhydride and subsequently removed by a mild extractive workup with NaHCO3 (sat.). The N-acyl group can conveniently be exchanged from N-phenoxycarbonyl to N-tBoc, thus allowing orthogonal deprotection strategies. Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2003.

Compounds with activity on muscarinic receptors

-

, (2008/06/13)

Compounds and methods are provided for the alleviation or treatment of diseases or conditions in which modification of muscarinic m1 receptor activity has a beneficial effect. In the method, a therapeutically effective amount of a selective muscarinic m1

Muscarinic agonists

-

, (2008/06/13)

Compounds and methods are provided for the treatment of disease conditions in which modification of cholinergic, especially muscarinic m1, m4, or both m1 and m4, receptor activity has a beneficial effect. In the method, an effective amount of a compound is administered to a patient in need of such treatment.

(Benzoylphenyl)piperidines: A new class of immunomodulators

Bellamy,Chazan,Dodey,Dutartre,Ou,Pascal,Robin

, p. 1545 - 1552 (2007/10/02)

A series of (benzoylphenyl)piperidines has been synthesized and evaluated for activity as immunomodulators. Several of these compounds show good activity in primary screening on the basis of the lymphocytes mitogenic response to Con A, PHA, and PWM. A chloro group in position 4 of the benzoyl moiety as well as an amino group (or a carbamate derivative) para to the piperidine nucleus seems to be essential for activity. The depicted compounds may be considered as the first examples of a new series of immunomodulators.

Mesogenic Esters of the 4-(Alkylpiperidino) Benzoic Acids

Adomenas, P.,Sirutkaitis, R.

, p. 269 - 276 (2007/10/02)

A number of alkyl and 4-substituted phenyl 4-(4-alkylpiperidino) benzoates have been prepared and their proprties examined.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 24152-39-4